← Leaderboards
Sunil Chada
Introgen Therapeutics, Inc.
$425,778
Attributed
$425,778
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$425,778 · 2
By mechanism
R43$425,778 · 2
Top collaborators
No co-investigators on record.
Most similar at Introgen Therapeutics, Inc.
Same institution · by research overlap
- Frederick F Lang$11,903,884
Others in their field
Top investigators on “Gene Targeting”
- David Heimbrook · Leidos Biomedical Research, Inc.$205,122,388
- Richard A Gibbs · Baylor College Of Medicine$161,086,449
- Barton F Haynes · Duke University$98,448,044
- Andrzej Joachimiak Joachimiak · University Of Chicago$94,692,413
- Eric Martin McDade · Washington University$94,632,845
- Stephen S. Rich · University Of Alabama At Birmingham$84,483,911
Research focus
Gene TargetingGene TherapyApoptosisNeoplastic CellAdenoviridaeGene Delivery SystemGene ExpressionGenetic TransductionImmunocytochemistryImmunologic Substance Development /PreparationInterdisciplinary CollaborationLaboratory MouseLung NeoplasmsMonoclonal AntibodyTerminal Nick End LabelingTranscription FactorTransfection /Expression VectorTumor Suppressor GenesXenotransplantationAntineoplasticsAthymic MouseBreast NeoplasmsCell Line